参考文献
[1]CHEN W, et al. Cancer statistics in China, 2015[J]. CA: A Cancer Journal for Clinicians, 2016.
[2]LEAL J, et al. Economic Burden of Bladder Cancer Across the European Union[J]. Eur Urol, 2016.
[3]BURGER M, et al. Epidemiology and risk factors of urothelial bladder cancer[J]. Eur Urol, 2013.
[4]FORBES S A, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer[J]. Nucleic Acids Res, 2011.
[5]GOEBELL P J, et al. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium[J]. Urol Oncol, 2010.
[6]KAMPA D, et al. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22[J]. Genome Res, 2004.
[7]PENNISI E. Shining a light on the genome’s “dark matter” [J]. Science, 2010.
[8]WALSH A L, et al. Long noncoding RNAs and prostate carcinogenesis: the missing “linc”? [J]. Trends Mol Med, 2014.
[9]JIA H, et al. Genome-wide computational identification and manual annotation of human long noncoding RNA genes[J]. RNA, 2010.
[10]DERRIEN T, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression[J]. Genome Res, 2012.
[11]HAN D, et al. Long noncoding RNAs: Novel players in colorectal cancer[J]. Cancer Letters, 2015.
[12]QIU M, et al. Long noncoding RNA: an emerging paradigm of cancer research[J]. Tumor Biology, 2013.
[13]PRENSNER J R, et al. The emergence of 1ncRNAs in cancer biology[J]. Cancer Discov, 2011.
[14]KUNG J T, et al. Long Noncoding RNAs: Past, Present, and Future[J]. Genetics, 2013.
[15]DEBALI S, et al. Landscape of transcription in human cells[J]. Nature, 2012.
[16]LEE J T. Epigenetic regulation by long noncoding RNAs. science, 2012.
[17]BROWN C J, et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome[J]. Nature, 1991.
[18]CLERC P, et al. New lessons from random X-chromosome inactivation in the mouse[J]. J Mol Biol, 2011.
[19]WEAKLEY S M, et al. Expression and function of a large non-coding RNA gene XIST in human cancer[J]. World J Surg, 2011.
[20]GUPTA R A, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J]. Nature, 2010.
[21]PETROVICS G, et al. Elevated expression of PCGEMI，a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients[J]. Oncogene, 2004.
[22]FU X, et al. Regulation of apoptosis by a prostate-specific and prostate cancer- associated noncoding gene, PCGEMI[J]. DNA Cell Biol, 2006.
[23]CHUNG S, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility[J]. Cancer Sci, 2011.
[24]YANG L, et al. 1ncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs[J]. Nature, 2013.
[25]FENG J, et al. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator[J]. Genes Dev, 2006.
[26]HUNG T, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters[J]. Nat Genet, 2011.
[27]TRIPATHI V, et al. The nuclear-retained noncoding RNA MALATI regulates alternative splicing by modulating SR splicing factor phosphorylation[J]. Mol Cell, 2010.
[28]GONG C, et al. 1ncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3’ UTRs via Alu elements[J]. Nature, 2011.
[29]FAGHIHI M A, et al. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase[J]. NatMed, 2008.
[30]YOON J H, et al. Long non-coding RNA-p21 suppresses target mRNA translation[J]. Mol Cell, 2012.
[31]CESANA M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell, 2011.
[32]BERNHART S H, et al. Post-transcriptional processing generates a diversity of 5’-modified long and short RNAs[J]. Nature, 2009.
[33]WANG J, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with RNA-372 in liver cancer[J]. Nucleic Acids Res, 2010.
[34]GUPTA R A, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J]. Nature, 2010.
[35]DOOSE G, et al. MINOR is a MYC-induced 1ncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells[J]. Proc Natl Acad Sci U S A, 2015.
[36]IYER M K, et al. The landscape of long noncoding RNAs in the human transcriptome [J]. Nat Genet, 2015.
[37]LUO M, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression[J]. Cancer Lett, 2013.
[38]ARIEl I, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma[J]. Mol Pathol, 2000.
[39]MATOUK I J, et al. The H19 non-coding RNA is essential for human tumor growth[J]. PLoS One, 2007.
[40]AMIT D, HOCHBERG A. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences[J]. J Transl Med, 2010.
[41]YING L, et al. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition[J]. Mol Biosyst, 2012.
[42]HAN Y, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder[J]. Urology, 2013.
[43]ZHOU Y, et al. MEG3 noncoding RNA: a tumor suppressor[J]. J Mol Endocrinol, 2012.
[44]ZHU Y, et al. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival[J]. Urology, 2011.
[45]HAN Y, et al. Long intergenic non-coding RNA TUGl is overexpressed in urothelial carcinoma of the bladder[J]. J Surg Oncol, 2013.
[46]WANG X S, et al. Rapid identification of UCA1 as asensitmeand specific unique marker for human bladder carcinoma[J]. Clin Cancer Res, 2006.
[47]YANG C, et al. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells[J]. Gene, 2012.
[48]SUN X, et al. Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer[J]. Cell Death Dis, 2015.
[49]MARTINEZ-FERNANDEZ M, et al. Analysis of the Polycomb-related 1ncRNAs HOTAIR and ANRIL in bladder cancer[J]. Clin Epigenetics, 2015.
[50]BERRONDO C, et al. Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes[J]. PLoS One, 2016.
[51]YAN T H, et al. Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer[J]. Tumour Biol, 2014.
[52]ZHU Y, et al. ncRAN, a Newly Identified Long Noncoding RNA, Enhances Human Bladder Tumor Growth, Invasion, and Survival[J]. Urology, 2011.
[53]ZHU H, et al. Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway[J]. Biochemical and Biophysical Research Communications, 2015.
[54]XUE Y, et al. A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer[J]. Oncotarget, 2015
[55]LI L J, et al. Long noncoding RNA GHET1 promotes the development of bladder cancer[J]. Int J Clin Exp Pathol, 2014.
[56]SHEVELEV A, et al. Increased expression of SUMOIP3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer[J]. Cancer Res, 2009.
[57]ELKIN M, et al. The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma[J]. FEBS Lett, 1995.
[58]BYUN H M, et al.Examination of IGF2 and H19 loss of imprinting in bladder cancer[J]. Cancer Res, 2007.
[59]COOPER M J, et al. Developmentally imprinted genes as markers for bladder tumor progression[J]. J Urol, 1996.
[60]LUO M, et al.Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression[J]. FEBS J, 2013.
[61]RAVEH E, et al.The H19 Long non-coding RNA in cancer initiation, progression and metastasis-a proposed unifying theory[J]. Mol Cancer, 2015.
[62]ZHANG X, et al.Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions[J]. Endocrinology, 2010.
[63]ZHOU Y, et al.Activation of p53 by MEG3 non-coding RNA[J]. J Biol Chem, 2007.
[64]YING L, et al.Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer[J]. Mol Biosyst, 2013.
[65]BENETATOS L, et al.The microRNAs within the DLK1-DI03 genomic region: involvement in disease pathogenesis[J]. Cell Mol Life Sci, 2013.
[66]WU W, et al.Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1，a long non-coding RNA, in bladder cancer cells[J]. PLoS One, 2013.
[67]WANG Y, et al.Long non-coding RNA UCAla promotes proliferation and tumorigenesis of bladder cancer[J]. Int J Oncol, 2012.
[68]LI Z, et al.Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway[J]. Cancer Sci, 2014.
[69]REN S, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings[J]. Cell Res, 2012.
[70]KHALIL A M, et al.Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression[J]. Proc Natl Acad Sci U S A, 2009.
[71]BERGER M F, et al.The genomic complexity of primary human prostate cancer[J]. Nature, 2011.